L'institut Saint-Antoine et la question de l'institutionnalisation des mineurs au Québec (1869-1950) : La jeunesse au Québec. Marges, institutions et représentations = The institut saint-antoine and the question of the institutionalization of minors in quebec (1869-1950)MENARD, Sylvie.Globe (Montréal.1998). 2005, Vol 8, Num 2, pp 73-90, issn 1481-5869, 18 p.Article

Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograftPRATESI, Graziella; PETRANGOLINI, Giovanna; TORTORETO, Monica et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6388-6393, issn 0008-5472, 6 p.Article

Immunological and pathobiological roles of fibulin-1 in breast cancerPUPA, Serenella M; ARGRAVES, Scott W; MORTARINI, Roberta et al.Oncogene (Basingstoke). 2004, Vol 23, Num 12, pp 2153-2160, issn 0950-9232, 8 p.Article

Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2GENNARI, Roberto; MENARD, Sylvie; OLIVIERO, Barbara et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5650-5655, issn 1078-0432, 6 p.Article

Role of proliferation in HER2 status predicted response to doxorubicinCAMPIGLIO, Manuela; SOMENZI, Giulia; OLGIATI, Clelia et al.International journal of cancer. 2003, Vol 105, Num 4, pp 568-573, issn 0020-7136, 6 p.Article

SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitroORLANDI, Rosaria; CATTANEO, Monica; TROGLIO, Flavia et al.Cancer research (Baltimore). 2002, Vol 62, Num 2, pp 567-574, issn 0008-5472Article

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerIORIO, Marilena V; CASALINI, Patrizia; TAGLIABUE, Elda et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2753-2759, issn 0959-8049, 7 p.Article

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2VARCHETTA, Stefania; GIBELLI, Nadia; COSTA, Alberto et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11991-11999, issn 0008-5472, 9 p.Article

Linking survival of HER2-positive breast carcinoma patients with surgical invasivenessTAGLIABUE, Elda; AGRESTI, Roberto; CASALINI, Patrizia et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 1057-1061, issn 0959-8049, 5 p.Article

SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivoCATTANEO, Monica; ORLANDINI, Simonetta; MENARD, Sylvie et al.Oncogene (Basingstoke). 2003, Vol 22, Num 41, pp 6359-6368, issn 0950-9232, 10 p.Article

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviorsMENARD, Sylvie; BALSARI, Andrea; CASALINI, Patrizia et al.Clinical cancer research. 2002, Vol 8, Num 2, pp 520-525, issn 1078-0432Article

Axillary Lymph Node Dissection Versus No Dissection in Patients With T1NO Breast Cancer: A Randomized Clinical Trial (INT09/98)AGRESTI, Roberto; MARTELLI, Gabriele; BIANCHI, Giulia et al.Cancer. 2014, Vol 120, Num 6, pp 885-893, issn 0008-543X, 9 p.Article

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyCAMPIGLIO, Manuela; BUFALINO, Rosaria; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 147-154, issn 0167-6806, 8 p.Article

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signalingNORMANNO, Nicola; CAMPIGLIO, Manuela; MAIELLO, Monica R et al.Breast cancer research and treatment. 2008, Vol 112, Num 1, pp 25-33, issn 0167-6806, 9 p.Article

Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccinationPUPA, Serenella M; IEZZI, Manuela; DI CARLO, Emma et al.Cancer research (Baltimore). 2005, Vol 65, Num 3, pp 1071-1078, issn 0008-5472, 8 p.Article

MicroRNA gene expression deregulation in human breast cancerIORIO, Marilena V; FERRACIN, Manuela; MENARD, Sylvie et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7065-7070, issn 0008-5472, 6 p.Article

CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory responseSFONDRINI, Lucia; BESUSSO, Dario; BRONTE, Vincenzo et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 8, pp 697-704, issn 0340-7004, 8 p.Article

HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancerMOLITERNI, Angela; MENARD, Sylvie; BONADONNA, Gianni et al.Journal of clinical oncology. 2003, Vol 21, Num 3, pp 458-462, issn 0732-183X, 5 p.Article

Identification of a novel function for 67-kDa laminin receptor: Increase in laminin degradation rate and release of motility fragmentsARDINI, Elena; SPORCHIA, Barbara; POLLEGIONI, Loredano et al.Cancer research (Baltimore). 2002, Vol 62, Num 5, pp 1321-1325, issn 0008-5472Article

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesMENARD, Sylvie; VALAGUSSA, Pinuccia; CASCINELLI, Natale et al.Journal of clinical oncology. 2001, Vol 19, Num 2, pp 329-335, issn 0732-183XArticle

Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive toTrastuzumabMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2010-2021, issn 1078-0432, 12 p.Article

microRNA-205 Regulates HER3 in Human Breast CancerLORIO, Marilena V; CASALINI, Patrizia; PIOVAN, Claudia et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 6, pp 2195-2200, issn 0008-5472, 6 p.Article

Two Distinct Local Relapse Subtypes in Invasive Breast Cancer : Effect on their Prognostic ImpactCASALINI, Patrizia; CARCANGIU, Maria Luisa; TAMMI, Raija et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 25-31, issn 1078-0432, 7 p.Article

Protein kinase Cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplificationMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5308-5317, issn 0008-5472, 10 p.Article